MAbxience | Finanzwire

Basculer en Français

11149	Companies
245941	Keywords
173928	Articles
132730	Press releases

Home
Companies
MAbxience

BRIEF

published on 10/01/2026 at 07:10, 7 days 12 hours ago

Fresenius Acquires Full Ownership of mAbxience

Acquisition Biosimilars Biopharma Fresenius MAbxience
PRESS RELEASE

published on 10/01/2026 at 07:05, 7 days 13 hours ago

Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
Fresenius completes acquisition of mAbxience, enhancing biosimilars platform to support future innovation and patient access. Full ownership strengthens quality and supply resilience

Acquisition Innovation Biosimilars Fresenius MAbxience
BRIEF

published on 09/18/2026 at 12:40, 20 days 7 hours ago

MAbxience and Sandoz Join Forces to Enhance Global Access to Biosimilars

Biosimilar Global Healthcare Sandoz Hemophilia A MAbxience
PRESS RELEASE

published on 09/18/2026 at 12:35, 20 days 7 hours ago

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
mAbxience and Sandoz sign a collaboration agreement to advance biosimilar access worldwide, combining development and commercial expertise to broaden patient access to high-quality biologic medicines

Collaboration Agreement Sandoz MAbxience Emicizumab Biosimilar Access
BRIEF

published on 12/22/2025 at 22:10, 9 months 16 days ago

FDA Approves mAbxience and Amneal's Denosumab Biosimilars

FDA Approval Amneal Pharmaceuticals Denosumab Biosimilars MAbxience Affordable Biologics
PRESS RELEASE

published on 12/22/2025 at 22:05, 9 months 16 days ago

mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
mAbxience and Amneal announced FDA approval of denosumab biosimilars referencing Prolia and XGEVA, expanding affordable biologic access in the US

FDA Approval Denosumab Biosimilars MAbxience Amneal Prolia XGEVA
BRIEF

published on 12/04/2025 at 09:10, 10 months 4 days ago

MAbxience and HP Collaborate on AI in Biomanufacturing

Artificial Intelligence Biosimilars Biomanufacturing MAbxience HP Inc.
PRESS RELEASE

published on 12/04/2025 at 09:05, 10 months 4 days ago

mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies

AI Solution Biosimilar Development Biomanufacturing MAbxience HP

Accesswire

Published on 10/08/2026 at 14:31, 5 hours 34 minutes ago

First Breach Expands Hiring Initiative to Support Ammunition Production Growth and Planned Drone Manufacturing Operations
Published on 10/08/2026 at 14:30, 5 hours 35 minutes ago

Predictiv AI's Shift AI Completes AWS Foundational Technical Review and Expands Aviation Visibility Through AWS Solutions Library
Published on 10/08/2026 at 14:00, 6 hours 5 minutes ago

Earthwise Minerals Appoints Andy Randell, P.Geo., to Board of Directors
Published on 10/08/2026 at 14:00, 6 hours 5 minutes ago

Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia
Published on 10/08/2026 at 14:00, 6 hours 5 minutes ago

Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth

View all ACCESSWIRE

EQS Group

Published on 10/08/2026 at 19:01, 1 hour 4 minutes ago

LightOn releases LightOnOCR-3, a world-leading model family for document intelligence.
Published on 10/08/2026 at 18:30, 1 hour 35 minutes ago

Form 8 (OPD) - Irish Residential Properties REIT plc
Published on 10/08/2026 at 18:00, 2 hours 5 minutes ago

ROCTOOL: 2026 HALF-YEAR RESULTS - Stronger sales momentum and a promising second half of the year
Published on 10/08/2026 at 17:52, 2 hours 13 minutes ago

Verbio SE: Verbio Capital Markets Day 2026: Transforming structural expansion into sustainable value creation
Published on 10/08/2026 at 17:30, 2 hours 35 minutes ago

EQS-Adhoc: Shelly Group Reports Preliminary Consolidated Revenue for the First Nine Months of 2026

Les Echos

Published on 10/08/2026 at 18:30, 1 hour 35 minutes ago

Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 2 hours 5 minutes ago

Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 2 hours 20 minutes ago

Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
Published on 10/07/2026 at 18:19, 1 day 1 hour ago

Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:46, 1 day 2 hours ago

Press release 7 October 2026

View all LES ECHOS COMFI WIRE